View in EDS

AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.

Saved in:
Bibliographic Details
Title: AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.
Authors: Wu A; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Dumo CJ; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Cook WH; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Richards I; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Macapagal Foliaki J; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Cooper E; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Fong DM; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Mouravlev A; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Park TI; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Dragunow M; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Young D; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 Apr 22; Vol. 34 (2), pp. 201216. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42110474
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wu+A%22">Wu A</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Dumo+CJ%22">Dumo CJ</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Cook+WH%22">Cook WH</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Richards+I%22">Richards I</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Macapagal+Foliaki+J%22">Macapagal Foliaki J</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Cooper+E%22">Cooper E</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Fong+DM%22">Fong DM</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Mouravlev+A%22">Mouravlev A</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Park+TI%22">Park TI</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Dragunow+M%22">Dragunow M</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.<br /><searchLink fieldCode="AU" term="%22Young+D%22">Young D</searchLink>; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2026 Apr 22; Vol. 34 (2), pp. 201216. <i>Date of Electronic Publication: </i>2026 Apr 22 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42110474
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omton.2026.201216
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 201216
    Titles:
      – TitleFull: AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wu A
      – PersonEntity:
          Name:
            NameFull: Dumo CJ
      – PersonEntity:
          Name:
            NameFull: Cook WH
      – PersonEntity:
          Name:
            NameFull: Richards I
      – PersonEntity:
          Name:
            NameFull: Macapagal Foliaki J
      – PersonEntity:
          Name:
            NameFull: Cooper E
      – PersonEntity:
          Name:
            NameFull: Fong DM
      – PersonEntity:
          Name:
            NameFull: Mouravlev A
      – PersonEntity:
          Name:
            NameFull: Park TI
      – PersonEntity:
          Name:
            NameFull: Dragunow M
      – PersonEntity:
          Name:
            NameFull: Young D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 04
              Text: 2026 Apr 22
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2950-3299
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Molecular therapy. Oncology
              Type: main
ResultId 1